The feasibility of using pathobiome strains as live biotherapeutic products for human use

Pengfei Jin; Xiong Lin; Wenfeng Xu; Kangning Li; Xiaoxiao Zhao; Sirui Guo; Zinan Zhao; Lujie Jiang; Feng Liao; Longgang Chang; Min Wang; Yanmin Liu; Shaolei Huang; Zhangran Chen; Fusui Ji

doi:10.1002/imt2.202

iMeta ›› 2024, Vol. 3 ›› Issue (3) : 202 DOI: 10.1002/imt2.202

COMMENTARY

The feasibility of using pathobiome strains as live biotherapeutic products for human use

Pengfei Jin ¹
, Xiong Lin ²
, Wenfeng Xu ¹
, Kangning Li ²
, Xiaoxiao Zhao ²
, Sirui Guo ¹
, Zinan Zhao ¹
, Lujie Jiang ²
, Feng Liao ²
, Longgang Chang ²
, Min Wang ²
, Yanmin Liu ²
, Shaolei Huang ²
, Zhangran Chen ²^,^†
, Fusui Ji ³^,^†

Author information +

History +

PDF

Cite this article

Download citation ▾

Pengfei Jin, Xiong Lin, Wenfeng Xu, Kangning Li, Xiaoxiao Zhao, Sirui Guo, Zinan Zhao, Lujie Jiang, Feng Liao, Longgang Chang, Min Wang, Yanmin Liu, Shaolei Huang, Zhangran Chen, Fusui Ji. The feasibility of using pathobiome strains as live biotherapeutic products for human use. iMeta, 2024, 3(3): 202 DOI:10.1002/imt2.202